Activity and safety of cabozantinib in patients with gastrointestinal stromal tumor after failure of imatinib and sunitinib: EORTC phase II trial 1317 CaboGIST.

Affiliation auteurs!!!! Error affiliation !!!!
TitreActivity and safety of cabozantinib in patients with gastrointestinal stromal tumor after failure of imatinib and sunitinib: EORTC phase II trial 1317 CaboGIST.
Type de publicationJournal Article
Year of Publication2019
AuteursSchoffski P, Mir O, Kasper B, Papai Z, Blay J-Y, Italiano A, Benson C, Kopeckova K, Ali N, Dileo P, Le Cesne A, Menge F, Cousin S, Charon-Barra C, Wozniak A, Marreaud S, Litiere S, Nzokirantevye A, Gelderblom H
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X